BugSeq

Want to learn more about our AMR prediction? See our recent blog post: docs.bugseq.com/blog/2025/07...

Amaral et al. found a discordance between BIOFIRE BCID2 and #AMR phenotype. Read how BugSeq’s curated database enabled frameshift detection in a CTX-M and accurate phenotype prediction: doi.org/10.1016/j.di...

🚨 Headed to #ADLM2025? Come say hi to the BugSeq team at Booth 1064!

We’re showcasing the future of infectious disease assays with rapid, accurate, and interpretable genomic solutions.

Let’s talk metagenomics, AMR, and more 🧬👩‍🔬

#ADLM2025 #microbiology #genomics #AMR @myadlm.bsky.social

Read it here 👉 docs.bugseq.com/blog/2025/07...

#AMR #Genomics #Bioinformatics #MachineLearning #AST #gAST #microbiology

New blog post: Enabling Phenotypic AMR Prediction from NGS Data

We explore the strengths and pitfalls of current methods—and why BugSeq’s approach, combining expert-augmented ML with a curated database, delivers more accurate, interpretable phenotypic predictions from NGS data.

The first half of 2025 marked a significant leap forward for the BugSeq Bioinformatics platform, delivering powerful new capabilities to tackle the most pressing challenges in infectious disease. Read some of our highlights in our recent blog post: docs.bugseq.com/blog/2025/06...

Can’t make the poster session? Visit us at Booth 911 all weekend to learn more about how BugSeq can serve your bioinformatic needs!

We detail how a combination of long-read 16S sequencing, high-accuracy bioinformatic tools harnessing a curated reference database, and reporting that is aligned with clinical standards for amplicon-based pathogen detection can be an effective tool for pathogen detection in clinical specimens.

At #ASMMicrobe today? Check out the Clinical Public Health Microbiology poster session (CPHM-Saturday-289) between 10:30-11:30am or 4:00-5:00pm to learn more about BugSeq’s updated, clinically-oriented workflow for 16S analysis from @nanoporetech.com sequence data.

Attending #ASMicrobe this weekend? Visit the BugSeq booth (#911) to learn more about BugSeq’s comprehensive bioinformatics platform for applied microbiology and infectious disease applications!

Automated sample-to-answer workflows for whole-genome sequencing to investigate hospital-acquired infections **Biography**<br><br>Dr Michael Wiley is an Associate Professor at the University of Nebraska Medical Center and Director of Genomic Epidemiology for the Nebraska Public Health Laboratory. He is also ...

Did you miss Dr. Michael Wiley’s (@unmc.bsky.social) talk at #nanoporeconf? Watch it now online: nanoporetech.com/resource-cen...

In it, Dr. Wiley demonstrates the use of BugSeq in Nebraska for outbreak detection and investigation.
#PublicHealth #AMR #LondonCalling2025 @nanoporetech.com

BugSeq strengthens our partnership with ONT at #nanoporeconf: we are delighted to work with @nanoporetech.com towards achieving end-to-end infectious disease solutions with integration across technology stacks.

At #APHL? Drop by booth 500 to see how public health labs are using BugSeq to visualize and manage complex data from outbreaks before they spread. In addition - wastewater, viral surveillance, and pathogen detection - we got it all!
@aphl.org

The medical microbiology laboratory at @vchhealthcare.bsky.social used #BugSeq to predict and understand the mechanism of resistance to this last-line antibiotic in extremely drug resistant (#XDR) bacteria 👇

AMR causes the loss of >1 million lives annually, and aztreonam-avibactam is one of the newest drugs in our arsenal to combat #AMR and its attributable mortality, with approval in 2024 in EU/UK and 2025 in USA.

At #AMMICACMID2025? We are at booth #30 showing how labs are using BugSeq’s AI-powered bioinformatics to support sequencing isolates for #AMR prediction and epidemiologic surveillance, as well as 16S/ITS sequencing for identification of pathogens from culture-negative samples.

Missed Dr. Trish Simner’s (@mayoclinic.org) #ESCMIDGlobal 2025 presentation on using WGS for #AMR prediction? We spotted some data from the BugSeq team on the additive value of our database curation and machine learning which drives BugSeq’s mechanistic and interpretable AMR prediction service.

Our work to bring a near-patient, rapid mNGS system, powered by BugSeq’s bioinformatics to market in the EU: Genomic data. Insights. Action (II): Rapid mNGS for emergency response (RANGER) for HERA's next-generation cross-border threat capability
Innovation Theatre: April 14th 11:30-11:50am CEST

Learn more about BugSeq’s recent feature additions and our comprehensive offering of bioinformatic tools for infectious disease and microbiology applications:
Pipeline Corner (Arena 4): April 14th 1:30-2:30pm CEST

Also, be sure to check out some of these sessions from the BugSeq team:

At #ESCMIDGlobal? Come see how BugSeq has helped clinical labs implement successful infection prevention programs based on NGS, as well as integration of BugSeq within NGS-based diagnostic assays. Make sure to pick up some goodies as well at booth D98 👜📓🖊️🎉

At @aphl.org #IDLabCon? Come check out how BugSeq is helping states analyze, track and mitigate outbreaks within and across states. And of course - don’t forget to grab some swag!
#PublicHealth #WholeGenomeSequencing #WGS

New study shows MHRA collaboration with hospital DNA sequencing service cuts time to diagnose infections In a UK-first, the Medicines and Healthcare products Regulatory Agency (MHRA) and Barts Health NHS Trust have developed a DNA sequencing approach that can be implemented onsite in hospitals so they ca...

Read the MHRA press release: www.gov.uk/government/n...
Read the full study: doi.org/10.3389/fcim...

The study concludes, "the bioinformatics pipelines used in this study demonstrate potential solutions for laboratories without in-house bioinformaticians."

Researchers at @nhs.uk: "The BugSeq online platform was highly user-friendly" on the use of BugSeq for diagnosis of culture-negative infections using @nanoporetech.com 16S.

Discover how microbiology labs are tracking and mitigating outbreaks faster using BugSeq's data-driven platform: docs.bugseq.com/blog/2025/02...

BugSeq leads clinical bioinformatics in consortium (Ginkgo Jumpcode, Planet Innovation, TGen, and more) developing end-to-end metagenomic solution for HaDEA.

See our announcement here: bugseq.com/news/2025/02/20/BugSeq-RANGER-HaDEA

Learn more about BugSeq: bugseq.com